Rhone Ma Holdings

RHONEMA

MYL5278OO006

Pharmaceuticals

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
0.67 ^MYR	+0.75%		+1.52%	-2.90%

Apr. 17	Rhone Ma to Pay Final Dividend	MT
Apr. 16	Rhone Ma Holdings Berhad Announces Final Single Tier Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on July 15, 2024	CI

Rhone Ma Holdings Berhad Approves Final Single-Tier Dividend of the Financial Year Ended 31 December 2022

June 13, 2023 at 05:33 am EDT

Rhone Ma Holdings Berhad at its AGM held on 13 June 2023, approved the payment of Final Single-Tier Dividend of 1.0 sen per ordinary share in respect of the financial year ended 31 December 2022.

Latest news about Rhone Ma Holdings

Rhone Ma to Pay Final Dividend	Apr. 17	MT
Rhone Ma Holdings Berhad Announces Final Single Tier Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on July 15, 2024	Apr. 16	CI
Rhone Ma Holdings Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Rhone Ma Holdings Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Rhone Ma Holdings Berhad Announces Interim Single-Tier Dividend in Respect of the Financial Year Ending 31 December 2023, Payable on 02 February 2024	Dec. 15	CI
Rhone Ma's Profit Edges Down in Q3	Nov. 15	MT
Rhone Ma Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Rhone Ma's Profit, Revenue Drop in Q2	23-08-16	MT
Rhone Ma Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-15	CI
Rhone Ma Holdings Berhad Approves Final Single-Tier Dividend of the Financial Year Ended 31 December 2022	23-06-13	CI
Rhone Ma's Profit, Revenue Drop in Q1	23-05-17	MT
Rhone Ma Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-16	CI
Rhone Ma Holdings Berhad Announces Final Single-Tier Dividend in Respect of the Financial Year Ended 31 December 2022, Payable on 17 July 2023	23-04-11	CI
Rhone Ma JV to Develop Jemaluang Dairy Valley in Johor, Malaysia	23-04-07	MT
Rhone Ma Holdings Berhad Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-21	CI
Rhone Ma Holdings Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-21	CI
Rhone Ma Holdings Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2022, Payable on 16 January 2023	22-12-15	CI
Rhone Ma's Profit Flat, Revenue Jumps in Q3	22-11-16	MT
Rhone Ma Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-15	CI
Rhone Ma's Profit, Revenue Jump in Q2	22-08-17	MT
Rhone Ma Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Rhone Ma's Profit, Revenue Climb in Q1	22-05-18	MT
Rhone Ma Holdings Berhad Proposes Final Single Tier Dividend for the Financial Year Ended 31 December 2021	22-05-17	CI
Rhone Ma Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-17	CI
Rhone Ma Holdings Berhad Announces Final Single-Tier Dividend for the Financial Year Ended December 31, 2021, Payable on July 15, 2022	22-04-12	CI

Rhone Ma Holdings Berhad is a Malaysia-based investment holding company, which is engaged in the provision of management services to its subsidiaries. The Companyâs segments include Animal health products and equipment, which is engaged in marketing, trading, distribution and manufacturing of animal health products and equipment and undertaking research and development activities related to animal health, food safety and agriculture in animal health products; Food ingredients segment, which is engaged in distribution and supply of food ingredients to manufacturers within the food and beverage industry, and Others, which includes provision of diagnostic laboratory analyses and consultation services to the veterinary, agriculture and food industries, provision of tests and diagnostics services for human healthcare, conduct research and development in biotechnology and distribution of human healthcare and related products, management services and business of livestock.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Rhone Ma Holdings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.67 MYR

Average target price

0.68 MYR

Spread / Average Target

+1.49%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
RHONE MA HOLDINGS	-2.90%	31.09M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals